Stay updated on Sage-217 Adjunctive Therapy in Depression Clinical Trial

Sign up to get notified when there's something new on the Sage-217 Adjunctive Therapy in Depression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sage-217 Adjunctive Therapy in Depression Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The clinical trial record for NCT04476030 is now displayed, including details of the completed Phase 3 study of SAGE-217 (zuranolone) with an antidepressant versus placebo with an antidepressant in adults with major depressive disorder. The page also presents study eligibility, participating locations, outcome measures, and record documents.
    Difference
    87%
    Check dated 2026-11-07T14:04:26.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T15:14:22.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added describing the transition from “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434. The study page still displays a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-24T18:08:54.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T18:03:34.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T19:08:57.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    403 Forbidden error page now appears when loading the study record, replacing the previous content with a minimal header/footer and a '403 Forbidden' message. This indicates access to the study details is currently blocked rather than an update to the study data.
    Difference
    20%
    Check dated 2026-09-19T18:36:09.000Z thumbnail image

Stay in the know with updates to Sage-217 Adjunctive Therapy in Depression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sage-217 Adjunctive Therapy in Depression Clinical Trial page.